# Evaluation of magnetic resonance spectroscopy total sodium concentration measures, and associations with microstructure and physical impairment in cervical myelopathy

**Authors:** Bhavana S. Solanky, Ferran Prados, Carmen Tur, Francesco Grussu, Selma Al-Ahmad, Xixi Yang, Alessia Bianchi, Baris Kanber, Antonino Russo, Vittorio Russo, David Choi, Jalesh N. Panicker, Claudia A. M. Gandini Wheeler-Kingshott

PMC · DOI: 10.1038/s41598-025-91658-w · Scientific Reports · 2025-02-27

## TL;DR

This study uses magnetic resonance spectroscopy to measure sodium levels in cervical myelopathy patients and finds that lower neurite density is linked to physical impairment.

## Contribution

The study introduces the use of 23Na-MRS at 3T to measure tissue sodium concentration in cervical myelopathy and its association with microstructure and physical impairment.

## Key findings

- No significant difference in tissue sodium concentration was found between cervical myelopathy patients and healthy controls.
- Patients had a significantly lower cord-cross-sectional area compared to controls.
- Lower intracellular volume fraction was associated with lower extremity physical impairment.

## Abstract

Spinal cord injury causes a cascade of physiological responses, which may trigger a subsequent neurotoxic increase in intracellular sodium. This can lead to neurodegeneration, both at and beyond the site of injury, causing clinical symptoms and loss of function. However, in vivo measurements of tissue sodium remain challenging. Here we utilise sodium magnetic resonance spectroscopy (23Na-MRS) at 3T to measure tissue sodium concentration (TSC) and its association with microstructural measures and macromolecular MRI metrics in the cervical spinal cord, distal to the site of injury. Twenty people with cervical myelopathy and twenty healthy controls, were studied. Associations with motor and sensory impairments were explored using ASIA and jOAMEQ scores. No significant difference in TSC in the cervical myelopathy group (39 ± 10 mM) relative to healthy controls (35 ± 13 mM) was found. However, patients had a significantly lower cord-cross-sectional area than controls (70 ± 9 mm2 vs. 82 ± 9 mm2, p < 0.001). Lower-extremity function positively correlated with intracellular volume fraction (p = 0.031). In conclusion, using 23Na-MRS, TSC in cervical myelopathy patients was successfully measured. Differences in TSC relative to healthy controls did not reach significance, despite a significant reduction in cord-cross-sectional area. However, lower intracellular volume fraction, indicating reduced neurite density distal to the site of injury, was associated with physical impairment.

## Full-text entities

- **Diseases:** neurodegeneration (MESH:D019636), physical (MESH:D059445), cervical myelopathy (MESH:D002575), neurotoxic (MESH:D020258), loss of (MESH:D016388), Spinal cord injury (MESH:D013119), motor and sensory impairments (MESH:D015417)
- **Chemicals:** 23Na (-), sodium (MESH:D012964)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11868613/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11868613/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC11868613/full.md

---
Source: https://tomesphere.com/paper/PMC11868613